Skip to main content
SpringerLink
Log in

Blood Constituents and Safety Pharmacology

  • Reference work entry
Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays

  • 3295 Accesses

Abstract

The coagulation cascade consists of a complex network of interactions resulting in thrombin-mediated conversion of fibrinogen to fibrin, which is one major component of a thrombus. The coagulation cascade can be initiated either by the “exogenous pathway,” the release of thromboplastin (tissue factor) leading to activation of factor VII to the tissue factor/factor VIIa complex, or by the “endogenous pathway,” so-called contact activation leading via factors XII, XI, and IX to the assembly of the tenase complex consisting of activated factors VIII and IX and Ca2+ on a phospholipid surface. Both complexes can activate factor X, which induces the formation of the prothrombinase complex consisting of factor Xa, factor Va, and Ca2+ on a phospholipid’s surface. The latter leads to the activation of thrombin, which in turn cleaves fibrinogen to fibrin. The three coagulation tests (PT, APTT, and TT) allow differentiating between effects on the exogenous or endogenous pathway or on fibrin formation. The influence of compounds on the plasmatic blood coagulation is determined by measuring the coagulation parameters prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT) ex vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 799.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Further Reading

  • Abulencia JP, Tien N, McCarty OJT, Plymire D, Mousa SA, Konstantopoulos K (2001) Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and Abciximab (c7E3) in flow models of thrombosis. Arterioscler Thromb Vasc Biol 21:149–156

    Article  CAS  PubMed  Google Scholar 

  • Agnelli G, Pascucci C, Cosmi B, Nenci GG (1990) The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits. Thromb Haemost 63:204–207

    CAS  PubMed  Google Scholar 

  • Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV (1993) Real-time analysis of shear dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81:1263–1276.

    CAS  PubMed  Google Scholar 

  • Al-Wathiqui MH, Hartman JC, Brooks HL, Warltier DC (1988) Induction of cyclic flow reduction in the coronary, carotid, and femoral arteries of conscious chronically instrumented dogs. A model for investigating the role of platelets in severely constricted arteries. J Pharmacol Methods 20:85–92

    Article  CAS  PubMed  Google Scholar 

  • Ammit AJ, O’Neill C (1991) Rapid and selective measurement of platelet-activating factor using a quantitative bioassay of platelet aggregation. J Pharmacol Methods 26:7–21

    Article  CAS  PubMed  Google Scholar 

  • Angelillo-Scherrer A, deFrutos PG, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts MF, Herbert J-M, Collen D, Dahlbäck B, Carmeliet P (2001) Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 7:215–221

    Article  CAS  PubMed  Google Scholar 

  • Antman EM, TIMI 9B Investigators (1996) Hirudin in acute myocardial infarction: thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation 4:911–921

    Article  Google Scholar 

  • Apprill P, Schmitz JM, Campbell WB, Tilton G, Ashton J, Raheja S, Buja LM, Willerson JT (1985) Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and α-adrenergic receptors. Circulation 72:397–405

    Article  CAS  PubMed  Google Scholar 

  • Arfors KE, Dhall DP, Engeset J, Hint H, Matheson NA, Tangen O (1968) Biolaser endothelial trauma as a means of quantifying platelet activity in vivo. Nature 218:887–888

    Article  Google Scholar 

  • Aronson DL, Thomas DP (1985) Experimental studies on venous thrombosis: effect of coagulants, pro-coagulants and vessel contusion. Thromb Haemost 54:866–870

    CAS  PubMed  Google Scholar 

  • Aszodi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, Andersson KF, Kehrel B, Offermanns S, Faessler R (1999) The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMVBO J 18:37–48

    Article  CAS  Google Scholar 

  • Badimon L, Badimon JJ (1989) Mechanism of arterial thrombosis in non-parallel streamlines: Platelet thrombi grow on the apex of stenotic severely injured vessel wall. J Clin Invest 84:1134–1144

    Article  CAS  PubMed  Google Scholar 

  • Balasubramanian V, Grabowski E, Bini A, Nemerson Y (2002) Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 100:2787–2792

    Article  CAS  PubMed  Google Scholar 

  • Barabas E, Szell E, Bajusz S (1993) Screening for fibrinolysis inhibitory effect of synthetic thrombin inhibitors. Blood Coagul Fibrinolysis 4:243–248

    Article  CAS  PubMed  Google Scholar 

  • Baumgartner HR (1973) The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 5:167–179

    Article  CAS  PubMed  Google Scholar 

  • Benedict CR, Mathew B, Rex KA, Cartwright J, Sordahl LA (1986) Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 58:58–67

    Article  CAS  PubMed  Google Scholar 

  • Bennett JS, Vilaire G (1979) Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64:1393–1401

    Article  CAS  PubMed  Google Scholar 

  • Bernardi MM, Califf RM, Kleiman N, Ellis SG, Topol EJ (1993) Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. Am J Cardiol 72:1121–1125

    Article  CAS  PubMed  Google Scholar 

  • Bernat A, Vallee E, Maffrand JP (1986) A simple experimental model of thrombolysis in the rat: effect of urokinase and of the complex human plasminogen-streptokinase. Thromb Res 44(Suppl VI):112

    Article  Google Scholar 

  • Best CH, Cowan C, MacLean DL (1938) Heparin and the formation of white thrombi. J Physiol 92:20–31

    CAS  PubMed  Google Scholar 

  • Bevilacqua C, Finesso M, Prosdocimi M (1991) Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit. Thromb Res 62:263–273

    Article  CAS  PubMed  Google Scholar 

  • Bhargava AS, Freihuber G, Guenzel P (1980) Characterization of a new potent heparin. III. Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood. Arzneim Forsch/Drug Res 30:1256–1258

    CAS  Google Scholar 

  • Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazaazian HH (1995) Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10:119–121

    Article  CAS  PubMed  Google Scholar 

  • Bi L, Sarkar R, Naas T, Lawler AM, Pain J, Shumaker SL, Bedian V (1996) Further characterization of Factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 88:3446–3450

    CAS  PubMed  Google Scholar 

  • Bick RL (1995) Laboratory evaluation of platelet dysfunction. Clin Lab Med 15:1–38

    CAS  PubMed  Google Scholar 

  • Biemond BJ, Friederich PW, Levi M, Vlasuk GP, Büller H, ten Cate JW (1996) Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis. Circulation 93:153–160

    Article  CAS  PubMed  Google Scholar 

  • Born GVR (1962a) Quantitative investigations into the aggregation of blood platelets. J Physiol (London) 162:67P–68P

    Google Scholar 

  • Born GVR (1962b) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929

    Article  CAS  PubMed  Google Scholar 

  • Bostwick JS, Kasiewski CJ, Chu V, Klein SI, Sabatino RD, Perrone MH, Dunwiddie CT, Cook JJ, Leadley RJ Jr (1996) Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonist. Thromb Res 82:495–507

    Article  CAS  PubMed  Google Scholar 

  • Brassard JA, Meyers KM (1991) Evaluation of the buckle bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency. Thromb Haemost 65:191–195

    CAS  PubMed  Google Scholar 

  • Breddin HK (1989) Thrombosis and Virchow’s triad: what is established. Semin Thromb Haemost 15:237–239

    Article  CAS  Google Scholar 

  • Breddin K, Grun H, Krzywanek HJ, Schremmer WP (1975) Zur Messung der “spontanen” Thrombocytenaggregation. Plättchenaggregationstest III. Methodik. Klin Wschr 53:81–89

    Article  CAS  PubMed  Google Scholar 

  • Broersma RJ, Kutcher LW, Heminger EF (1991) The effect of thrombin inhibition in a rat arterial thrombosis model. Thromb Res 64:405–412

    Article  CAS  PubMed  Google Scholar 

  • Bugge TH, Suh TT, Flick MJ, Daugherty CC, Romer J, Solberg H, Ellis V, Dano K, Degen JL (1995) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 270:16886–16894

    Article  CAS  PubMed  Google Scholar 

  • Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EW, Degen JL (1996a) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 93:6258–6263

    Article  CAS  PubMed  Google Scholar 

  • Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL (1996b) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 93:5899–5904

    Article  CAS  PubMed  Google Scholar 

  • Bush LR, Patrick D (1986) The role of the endothelium in arterial thrombosis and the influence of antithrombotic therapy. Drug Dev Res 7:319–340

    Article  CAS  Google Scholar 

  • Butler KD, Maguire ED, Smith JR, Turnbull AA, Wallis RB, White AM (1982) Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation. Thromb Haemos 47:46–49

    CAS  Google Scholar 

  • Callas DD, Bacher P, Fareed J (1995) Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findings. Semin Thromb Hemost 21(2):166–176

    Article  CAS  PubMed  Google Scholar 

  • Cardinal DC, Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3:135–158

    Article  CAS  PubMed  Google Scholar 

  • Carmeliet P, Collen D (1999) New developments in the molecular biology of coagulation and fibrinolysis. In: Uprichard ACG, Gallagher KP (eds) Handbook of experimental pharmacology, vol 132. Antithrombotics. Springer, Berlin, pp 41–76

    Google Scholar 

  • Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D (1993) Plasminogen activator inhibitor-1 gene-deficient mice. J Clin Invest 92:2756–2760

    Article  CAS  PubMed  Google Scholar 

  • Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419–424

    Article  CAS  PubMed  Google Scholar 

  • Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D (1996) Role of tissue factor in embryonic blood vessel development. Nature 383:73–75

    Article  CAS  PubMed  Google Scholar 

  • Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J (1998) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419–424

    Article  Google Scholar 

  • Carrie D, Caranobe C, Saivin S, Houin G, Petitou M, Lormeau JC, Van Boeckel C, Meuleman D, Boneu B (1994) Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY 216. Blood 84(8):2571–2577

    CAS  PubMed  Google Scholar 

  • Chandler AB (1958) In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Lab Invest 7:110–114

    CAS  PubMed  Google Scholar 

  • Chen XS, Sheller JR, Johnson EN, Funk CD (1994) Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372:179–182

    Article  CAS  PubMed  Google Scholar 

  • Chi L, Rebello S, Lucchesi BR (1999) In vivo models of thrombosis. In: U’Prichard ACG, Gallagher KP (eds) Anti-thrombotics. Springer, Berlin/Heidelberg, pp 101–127

    Google Scholar 

  • Christie PD, Edelberg JM, Picard MH, Foulkes AS, Mamuya W, Weiler-Guettler H, Rubin RH, Gilbert P, Rosenberg RD (1999) A murine model of myocardial thrombosis. J Clin Invest 104:533–539

    Article  CAS  PubMed  Google Scholar 

  • Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F (1998) Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and safety of subcutaneous enoxaparin versus intravenous unfractionated heparin, in non-Q-wave coronary events. Am J Cardiol 82:19L–24L

    Article  CAS  PubMed  Google Scholar 

  • Collen D, Stassen JM, Verstraete M (1983) Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. J Clin Invest 71:368–376

    Article  CAS  PubMed  Google Scholar 

  • Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE, Leinbach RC, Brinker JA, Ludbrook PA, Yasuda I et al (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation 70:1012–1017

    Article  CAS  PubMed  Google Scholar 

  • Coller BS, Peerschke EI, Scudder LE, Sullivan CA (1983) A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoprotein’s IIb and/or IIIa. J Clin Invest 72:325–338

    Article  CAS  PubMed  Google Scholar 

  • Coller BS, Folts JD, Scudder LE, Smith SR (1986) Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood 68:783–786

    CAS  PubMed  Google Scholar 

  • Coller BS, Smith SR, Scudder LE, Jordan R, Folts JD (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GP IIb/IIIa receptor: correlation with bleeding time, platelet aggregation and blockade of GP IIb/IIIa receptors. Circulation 80:1766–1774

    Article  CAS  PubMed  Google Scholar 

  • Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516–519

    Article  CAS  PubMed  Google Scholar 

  • Cook NS, Zerwes H-G, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A (1993) Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemost 70:531–539

    CAS  PubMed  Google Scholar 

  • Cook JJ, Holahan MA, Lyle EA, Ramjit DR, Sitko GR, Stranieri MT, Stupienski RF III, Wallace AA, Hand EL, Gehret JR, Kothstein T, Drag MD, McCormick GY, Perkins JJ, Ihle NC, Duggan ME, Hartman GD, Gould RJ, Lynch JJ Jr (1996) Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217. J Pharmacol Exp Ther 278:62–73

    CAS  PubMed  Google Scholar 

  • Cox D, Motoyama Y, Seki J, Aoki T, Dohi M, Yoshida K (1992) Pentamadine: a non-peptide GPIIb/IIIa antagonist – in vitro studies on platelets from humans and other species. Thromb Haemost 68:731–736

    CAS  PubMed  Google Scholar 

  • Cui J, O’Shea KS, Purkayastha A, Saunders TL, Ginsburg D (1996) Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384:66–68

    Article  CAS  PubMed  Google Scholar 

  • Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD (1998) Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition. Arterioscler Thromb Vasc Biol 18:1342–1349

    Article  CAS  PubMed  Google Scholar 

  • Darrow AL, Fung-Leung WP, Ye RD, Santulli RJ, Cheung WM, Derian CK, Burns CL, Damiano BP, Zhou L, Keenan CM, Peterson PA, Andrade-Gordon P (1996) Biological consequences of thrombin receptor deficiency in mice. Thromb Haemost 76:860–866

    CAS  PubMed  Google Scholar 

  • Dejana E, Callioni A, Quintana A, DeGaetano G (1979) Bleeding time in laboratory animals. II – a comparison of different assay conditions in rats. Thromb Res 15:191–197

    Article  CAS  PubMed  Google Scholar 

  • Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD (1998) A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 95:9524–9529

    Article  CAS  PubMed  Google Scholar 

  • Dewanjee MK, Wu S, Kapadvanjwala M et al (1996) Reduction of platelet thrombi and emboli by L-arginine infusion during cardiopulmonary bypass in a pig model. J Thromb Thrombolysis 3:339–356

    Google Scholar 

  • Dewerchin M, van Nuffelen A, Wallays G, Bouché ML, Carmeliet P, Mulligan RCM, Collen D (1996) Generation and characterization of urokinase receptor deficient mice. J Clin Invest 97:870–878

    Article  CAS  PubMed  Google Scholar 

  • Dewerchin M, Liang Z, Moons L, Carmeliet P, Castellino FJ, Collen D, Rosen ED (2000) Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 83:185–190

    CAS  PubMed  Google Scholar 

  • Didisheim P (1972) Animal models useful in the study of thrombosis and antithrombotic agents. Prog Hemost Thromb 1:165–197

    CAS  PubMed  Google Scholar 

  • Döttl K, Ripke O (1936) Blutgerinnung und Blutungszeit. In: Medizin und Chemie, Leverkusen (Germany), Bayer, pp 267–273

    Google Scholar 

  • Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H (1999) Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1) CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162:3022–3030

    CAS  PubMed  Google Scholar 

  • Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or over-express the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232–237

    Article  CAS  PubMed  Google Scholar 

  • Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D (2000) Plasminogenactivator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 95:577–580

    CAS  PubMed  Google Scholar 

  • Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010–1017

    Article  CAS  PubMed  Google Scholar 

  • EPIC Investigators (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343:881–886

    Article  Google Scholar 

  • Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 346:74–76

    Article  CAS  PubMed  Google Scholar 

  • Eriksson BI, Ekman S, Lindbratt S, Baur M, Bach D, Torholm C, Kälebo P, Close PJ (1997) Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement. J Bone Joint Surg Am. 79(3):326–333

    Google Scholar 

  • Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, McGregor JL, de Gaetano G, Cerletti C (1996) Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta2 integrin CD11b/CD18. Blood 88:4183–4194

    CAS  PubMed  Google Scholar 

  • Evans JP, Brinkhous KM, Brayer GD, Reisner HM, High KA (1989) Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Sci USA 86:10095–10099

    Article  CAS  PubMed  Google Scholar 

  • Fareed J, Walenga JM, Kumar A, Rock A (1985) A modified stasis thrombosis model to study the antithrombotic action of heparin and its fractions. Semin Thromb Hemost 11:155–175

    Article  CAS  PubMed  Google Scholar 

  • Fitzgerald DJ, Wright F, FitzGerald GA (1989) Increased thromboxane biosynthesis during coronary thrombolysis: evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. Circ Res 65:83–94

    Article  CAS  PubMed  Google Scholar 

  • Folie BJ, McIntire LV, Lasslo A (1988) Effects of a novel antiplatelet agent in mural thrombogenesis on collagen-coated glass. Blood 72:1393–1400

    CAS  PubMed  Google Scholar 

  • Folts JD (1991) An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. Circulation 83(Suppl IV):IV-3–IV-14

    CAS  Google Scholar 

  • Folts JD, Rowe GG (1974) Cyclical reductions in coronary blood flow in coronary arteries with fixed partial obstruction and their inhibition with aspirin. Fed Proc 33:413

    Google Scholar 

  • Folts JD, Rowe GG (1988) Epinephrine reverses aspirin inhibition of in vivo platelet thrombus formation in stenosed dog coronary arteries. Thromb Res 50:507–516

    Article  CAS  PubMed  Google Scholar 

  • Folts JD, Crowell EB, Rowe GG (1976) Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54:365–370

    Article  CAS  PubMed  Google Scholar 

  • Folts JD, Gallagher K, Rowe GG (1982) Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 65:248–255

    Article  CAS  PubMed  Google Scholar 

  • Forsythe LT, Willis SE (1989) Evaluating oral mucosa bleeding times in healthy dogs using a spring loaded device. Can Vet J 30:344–345

    CAS  PubMed  Google Scholar 

  • Fratantoni JC, Poindexter BJ (1990) Measuring platelet aggregation with microplate reader. Am J Clin Pathol 94:613–617

    CAS  PubMed  Google Scholar 

  • Fu K, Izquierdo R, Vandevender D, Warpeha RL, Wolf H, Fareed J (1997) Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model. Thromb Res 86(5):355–361

    Article  CAS  PubMed  Google Scholar 

  • Gailani D, Lasky NM, Broze GJ (1997) A murine model of factor XI deficiency. Blood Coagul Fibrinolysis 8:134–144

    Article  CAS  PubMed  Google Scholar 

  • Gallimore MJ, Tyler HM, Shaw JTB (1971) The measurement of fibrinolysis in the rat. Thromb Diath Haemorrh 26:295–310

    CAS  PubMed  Google Scholar 

  • Giles AR, Tinlin S, Greenwood R (1982) A canine model of hemophilic (factor VIII:C deficiency) bleeding. Blood 60:727–730

    CAS  PubMed  Google Scholar 

  • Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb/IIIa Investigators (1996) A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335:775–782

    Article  Google Scholar 

  • Goel MS, Diamond SL (2004) Factor VIIa-mediated tenase function on activated platelets under flow. J Thromb Haemost 2:1402–1410

    Article  CAS  PubMed  Google Scholar 

  • Gold HK, Fallon JT, Yasuda T, Leinbach RC, Khaw BA, Newell JB, Guerrero JL, Vislosky PM, Hoyng CF, Grossbard E, Collen D (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator. Circulation 70:700–707

    Article  CAS  PubMed  Google Scholar 

  • Gold HK, Leinbach RC, Garabedian HD, Yasuda T, Johns JA, Grossbard EB, Palacios I, Collen D (1986) Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 73:347–352

    Article  CAS  PubMed  Google Scholar 

  • Gold HK, Coller BS, Yasuda T, Saito T, Fallon JT, Guerrero JL, Leinbach RC, Ziskind AA, Collen D (1988) Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GP IIb/IIIa antibody in a canine preparation. Circulation 77:670–677

    Article  CAS  PubMed  Google Scholar 

  • Gold HK, Yasuda T, Jang IK, Guerrero JL, Fallon JT, Leinbach RC (1991) Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus. Circulation 83:IV26–IV403

    CAS  PubMed  Google Scholar 

  • Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB, et al. (1993) Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol. 21(5):1039–1047

    Article  CAS  PubMed  Google Scholar 

  • Goldberg RK, Levine S, Fenster PE (1985) Management of patients after thrombolytic therapy for acute myocardial infarction. Clin Cardiol 8:455–459

    Article  CAS  PubMed  Google Scholar 

  • Gryglewski RJ, Korbut R, Ocetkiewicz A, Stachura J (1978) In vivo method for quantitation of anti-platelet potency of drugs. Naunyn Schmiedebergs Arch Pharmacol 302:25–30

    Article  CAS  PubMed  Google Scholar 

  • Guarini S (1996) A highly reproducible model of arterial thrombosis in rats. J Pharmacol Toxicol Methods 35:101–105

    Article  CAS  PubMed  Google Scholar 

  • Hansson PO, Welin L, Tibblin G, Eriksson H (1997) Deep vein thrombosis and pulmonary embolism in the general population. “The Study of Men Born in 1913”. Arch Intern Med 157:1665–1670

    Article  CAS  PubMed  Google Scholar 

  • Hara T, Yokoyama A, Tanabe K, Ishihara H, Iwamoto M (1995) DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats. Thromb Haemost 74:635–639

    CAS  PubMed  Google Scholar 

  • Harbauer G, Hiller W, Hellstern P (1984) Ein experimentelles Modell der venösen Thrombose am Kaninchen; Überprüfung seiner Brauchbarkeit mit low dose heparin. An experimental model of venous thrombosis in the rabbit; test of its usefulness with low-dose heparin. In: Koslowski L (ed) Chirurgisches Forum ‘84 für experimentelle und klinische Forschung. Springer, Berlin/Heidelberg/New York/Tokyo, pp 69–72

    Chapter  Google Scholar 

  • Harkness J (1971) The viscosity of human blood plasma; its measurement in health and disease. Biorheology 8:171–179

    CAS  PubMed  Google Scholar 

  • Hartert H (1948) Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wschr 26:577–583

    Article  CAS  PubMed  Google Scholar 

  • Haskel E, Abendschein DR (1989) Deaggregation of human platelets in vitro by an RGD analog antagonist of platelet glycoprotein IIb/IIIa receptors. Thromb Res 56:687–695

    Article  CAS  PubMed  Google Scholar 

  • Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V (1999) Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci USA 96:8120–8125

    Article  CAS  PubMed  Google Scholar 

  • Healy AM, Rayburn HB, Rosenberg RD, Weiler H (1995) Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 92:850–854

    Article  CAS  PubMed  Google Scholar 

  • Healy AM, Hancock WW, Christie PD, Rayburn HB, Rosenberg RD (1998) Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition. Blood 92:4188–4197

    CAS  PubMed  Google Scholar 

  • Heckel JL, Sandgren EP, Degen JL, Palmiter RD, Brinster RL (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62:447–456

    Article  CAS  PubMed  Google Scholar 

  • Henny ChP, TenCate H, TenCate JW, Moulijn AC, Sie TH, Warren P, Buller HR (1985) A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. J Lab Clin Med 106:187–196

    CAS  PubMed  Google Scholar 

  • Herbert JM, Bernat A, Dol F, Herault JP, Crepon B, Lormeau JC (1996) DX 9065A, a novel, synthetic selective and orally active inhibitor of factor Xa: in vitro and in vivo studies. J Pharmacol Exp Ther 276:1030–1038

    CAS  PubMed  Google Scholar 

  • Hergrueter CA, Handren J, Kersh R, May JW (1988) Human recombinant tissue-type plasminogen activator and its effect on microvascular thrombosis in the rabbit. Plast Reconstr Surg 81:418–424

    Article  CAS  PubMed  Google Scholar 

  • Herrmann KS (1983) Platelet aggregation induced in the hamster cheek pouch by a photochemical process with excited fluorescein-isothiocyanate-dextran. Microvasc Res 26:238–249

    Article  CAS  PubMed  Google Scholar 

  • Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5:56–63

    Article  CAS  PubMed  Google Scholar 

  • Hladovec J (1973) Experimental arterial thrombosis in rats with continuous registration. Thromb Diath Haemorrh 29:407–410

    Google Scholar 

  • Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Culleré M, Ross FP, Coller BS, Teitelbaum S, Hynes RO (1999) β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103:229–238

    Article  CAS  PubMed  Google Scholar 

  • Hollenbach S, Sinha U, Lin PH, Needham K, Frey L, Hancock T et al (1994) A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis. Thromb Haemost 71:357–362

    CAS  PubMed  Google Scholar 

  • Hollenbach SJ, Wong AG, Ku P, Needham KM, Lin PH, Sinha U (1995) Efficacy of FXa inhibitors in a rabbit model of venous thrombosis. Circulation 92:I486–I487

    Google Scholar 

  • Huang Z-F, Higuchi D, Lasky N, Broze GJ Jr (1997) Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 90:944–951

    CAS  PubMed  Google Scholar 

  • Huang L, Kuo YM, Gitschier J (1999) The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat Genet 23:329–332

    Article  CAS  PubMed  Google Scholar 

  • Ikeda H, Ueyama T, Murohara T, Yasukawa H, Haramaki N, Eguchi H, Katoh A, Takajo Y et al (1999) Adhesive interaction between P-selectin and sialyl Lewis X plays an important role in recurrent coronary arterial thrombosis in dogs. Arterioscler Thromb Vasc Biol 19:1083–1090

    Article  CAS  PubMed  Google Scholar 

  • Jackson CV, Bailey BD, Shetler TJ (2000) Pharmacological profile of recombinant human activated protein C (LY203638) in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 295:957–971

    Google Scholar 

  • Jalbert LR, Rosen ED, Moons L, Chan JCY, Carmeliet P (1998) Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest 102:1481–1488

    Article  CAS  PubMed  Google Scholar 

  • Jang IK, Gold HK, Ziskind AA, Fallon JT, Leinbach RC, May JW, Collen D (1989) Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. Circulation 79:920–928

    Article  CAS  PubMed  Google Scholar 

  • Jang IK, Gold HK, Ziskind AA, Leinbach RC, Fallon JT, Collen D (1990) Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation 81:219–225

    Article  CAS  PubMed  Google Scholar 

  • Jen CJ, McIntire LV (1984) Characteristics of shear-induced aggregation in whole blood. J Lab Clin Med 103:115–124

    CAS  PubMed  Google Scholar 

  • Johnson EN, Brass LF, Funk CD (1998) Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase. Proc Natl Acad Sci USA 95:3100–3105

    Article  CAS  PubMed  Google Scholar 

  • Just M (1986) Pharmakologische Beeinflussung einer experimentellen Thrombose beim Kaninchen. Influence of various agents on experimental thrombosis in the rabbit. In: Wenzel E, Hellstern P, Morgenstern E, Köhler M, von Blohn G (eds) Rationelle Therapie und Diagnose von hämorrhagischen und thrombophilen Diathesen. Schattauer, Stuttgart/New York, pp 4.95–4.98

    Google Scholar 

  • Just M, Schönafinger K (1991) Antithrombotic properties of a novel sydnonimine derivative. J Cardiovasc Pharmacol 17(Suppl 3):S121–S126

    Article  CAS  Google Scholar 

  • Just M, Tripier D, Seiffge D (1991) Antithrombotic effects of recombinant hirudin in different animal models. Haemostasis 21(Suppl 1):80–87

    CAS  PubMed  Google Scholar 

  • Kahn ML, Zheng Y-W, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Tam C, Coughlin SR (1998) A dual thrombin receptor system for platelet activation. Nature 394:690–694

    Article  CAS  PubMed  Google Scholar 

  • Kararli TT (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Disp 16:351–380

    Article  CAS  Google Scholar 

  • Kawasaki T, Dewerchin M, Lijnen HR, Vermylen J, Hoylaerts MF (2000) Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice. Blood 96:153–160

    CAS  PubMed  Google Scholar 

  • Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, Glader B, Chew AJ, Tai SJ, Herzog RW, Arruda V, Johnson F, Scallan C, Skarsgard E, Flake AW, High KA (2000) Evidence for gene transfer and expression of factor IX in haemophilia B patients with an AAV vector. Nat Genet 24:257–261

    Article  CAS  PubMed  Google Scholar 

  • Khurana S, Mattson JC, Westley S, O’Neill WW, Timmis GC, Safian RD (1997) Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 130:401–411

    Article  CAS  PubMed  Google Scholar 

  • Kiesewetter H, Dauer M, Teitel P, Schmid-Schoenbein H, Trapp R (1982a) The single erythrocyte rigidometer (SER) as a reference for RBC deformability. Biorheology 19:737–753

    CAS  PubMed  Google Scholar 

  • Kiesewetter H, Radtke H, Schneider R, Mußler K, Scheffler A, Schmid-Schönbein H (1982b) Das Mini-Erythrozyten-Aggregometer: Ein neues Gerät zur schnellen Quantifizierung des Ausmaßes der Erythrocytenaggregation. Mini Erythrocyte aggregometer: a new apparatus for rapid quantification of the extent of erythrocyte aggregation. Biomed Tech 27:209–213

    Article  CAS  Google Scholar 

  • Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR (1994) Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 93:2073–2083

    Article  CAS  PubMed  Google Scholar 

  • Klement P, Liao P, Hirsh J, Jonston M, Weitz JI (1998) Hirudin causes more bleeding than heparin in a rabbit ear bleeding model. J Lab Clin Med 132:181–185

    Article  CAS  PubMed  Google Scholar 

  • Klose HJ, Rieger H, Schmid-Schönbein H (1975) A rheological method for the quantification of platelet aggregation (PA) in vitro and its kinetics under defined flow conditions. Thromb Res 7:261–272

    Article  CAS  PubMed  Google Scholar 

  • Knabb RM, Ketenner CA, Timmermanns PB, Reilly TM (1992) In vivo characterization of a new thrombin inhibitor. Thromb Haemost 67:56–59

    CAS  PubMed  Google Scholar 

  • Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, Ruggeri ZM (2006) Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 4:2014–2021

    Article  CAS  PubMed  Google Scholar 

  • Konstantopoulos K, Kamat SG, Schafer AI, Bañez EI, Jordan R, Kleiman NS, Hellums JD (1995) Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation 91:1427–1431

    Article  CAS  PubMed  Google Scholar 

  • Konstantopoulos K, Kukreti S, McIntire LV (1998) Biomechanics of cell interactions in shear fields. Adv Drug Deliv Rev 33:141–164

    Article  CAS  PubMed  Google Scholar 

  • Kopia GA, Kopaciewicz LJ, Ruffolo RR (1988) Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose–response study. J Pharmacol Exp Ther 244:956–962

    CAS  PubMed  Google Scholar 

  • Kornecki E, Niewiarowski S, Morinelli TA, Kloczewiak M (1981) Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann’s thrombasthenic platelets. J Biol Chem 256:5696–5701

    CAS  PubMed  Google Scholar 

  • Korompilias AV, Chen LE, Seaber AV, Urbaniak JR (1997) Antithrombotic potencies of enoxaparin in microvascular surgery: influence of dose and administration methods on patency rate or crushed arterial anastomoses. J Hand Surg Am 22(3):540–546

    Article  CAS  PubMed  Google Scholar 

  • Kumada T, Ishihara M, Ogawa H, Abiko Y (1980) Experimental model of venous thrombosis in rats and effect of some agents. Thromb Res 18:189–203

    Article  CAS  PubMed  Google Scholar 

  • Kundu RK, Sangiorgi F, Wu LY, Karachi K, Anderson WF, Maxson R, Gordon EM (1998) Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice. Blood 92:168–174

    CAS  PubMed  Google Scholar 

  • Kung J, Hagstrom J, Cass D, Tai S, Lin HF, Stafford DW, High KA (1998) Human FIX corrects bleeding diathesis of mice with hemophilia B. Blood 91:784–790

    CAS  PubMed  Google Scholar 

  • Kurz KD, Main BW, Sandusky GE (1990) Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 60:269–280

    Article  CAS  PubMed  Google Scholar 

  • Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR (1999) Integrin cytoplasmic tyrosine motif is required for outside-in αllbβ3 signalling and platelet function. Nature 401:808–811

    Article  CAS  PubMed  Google Scholar 

  • Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101:982–992

    Article  CAS  PubMed  Google Scholar 

  • Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, Dunwiddie CT, Perrone MH (1998) Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin. Arterioscler Thromb Vasc Biol 18:908–914

    Article  CAS  PubMed  Google Scholar 

  • Leadley RJ, Chi L, Rebello SS, Gagnon A (2000) Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. J Pharmacol Toxicol Methods 43:101–116

    Article  CAS  PubMed  Google Scholar 

  • Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave J-P, Gachet C (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 104:1731–1737

    Article  CAS  PubMed  Google Scholar 

  • Levi M, Biemond BJ, VanZonneveld AJ, ten Cate JW, Pannekoek H (1992) Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 85:305–312

    Article  CAS  PubMed  Google Scholar 

  • Lin H-F, Maeda N, Sithies O, Straight DL, Stafford DW (1997) A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90:3962–3966

    CAS  PubMed  Google Scholar 

  • Lind SE (1991) The bleeding time does not predict surgical bleeding. Blood 77:2547–2552

    CAS  PubMed  Google Scholar 

  • Lumley P, Humphrey PP (1981) A method for quantitating platelet aggregation and analyzing drug-receptor interactions on platelets in whole blood in vitro. J Pharmacol Methods 6(2):153–166

    Article  CAS  PubMed  Google Scholar 

  • Lutz BR, Fulton GP, Akers RP (1951) White thromboembolism in the hamster cheek pouch after trauma, infection and neoplasia. Circulation III:339–351

    Article  Google Scholar 

  • Lyle EM, Fujita T, Conner MW, Connolly TM, Vlasuk GP, Lynch JL Jr (1995) Effect of inhibitors of factor Xa or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury. J Pharmacol Toxicol Methods 33:53–61

    Article  CAS  PubMed  Google Scholar 

  • Lynch JJ Jr, Sitko GR, Lehman ED, Vlasuk GP (1995) Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model. Thromb Haemost 74:640–645

    CAS  PubMed  Google Scholar 

  • Mahooti S, Graesser D, Patil S, Newman P, Duncan G, Mak T, Madri JA (2000) PECAM-1 (CD 31) expression modulates bleeding tome in vivo. Am J Pathol 157:75–81

    Article  CAS  PubMed  Google Scholar 

  • Marguerie GA, Plow EF, Edgington TS (1979) Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 254(12):5357–5363

    CAS  PubMed  Google Scholar 

  • Marguerie GA, Edgington TS, Plow EF (1980) Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 255(1):154–161

    CAS  PubMed  Google Scholar 

  • Markell MS, Fernandez J, Naik UP, Ehrlich Y, Kornecki E (1993) Effects of cyclosporine-A and cyclosporine-G on ADP-stimulated aggregation of human platelets. Ann N Y Acad Sci 969:404–407

    Google Scholar 

  • Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, Faessler R, Ruth P, Krombach F, Hofmann F (1999) Increased adhesion and aggregation of platelets lacking cyclic guanosine 3’,5’-monophosphate kinase I. J Exp Med 189:1255–1264

    Article  CAS  PubMed  Google Scholar 

  • Matsuno H, Uematsu T, Nagashima S, Nakashima M (1991) Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods 25:303–317

    Article  CAS  PubMed  Google Scholar 

  • Matsuo O, Rijken DC, Collen D (1981) Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature 291:590–591

    Article  CAS  PubMed  Google Scholar 

  • Matsuo T, Koide M, Sakuramoto H, Matsuo M, Fuji K (1997) Small size of platelets aggregates detected by light scattering in young habitual smokers. Thromb Haemost 71(suppl):71

    Google Scholar 

  • McHugh KP, Hodivala-Dilke K, Zheng M-H, Namba N, Lam J (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433–440

    Article  CAS  PubMed  Google Scholar 

  • Mehta JL, Chen L, Nichols WW, Mattson C, Gustafsson D, Saldeen TG (1998) Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery. J Cardiovasc Pharmacol 31:345–351

    Article  CAS  PubMed  Google Scholar 

  • Mellot MJ, Stranieri MT, Sitko GR, Stabilito II, Lynch JJ Jr, Vlasuk GP (1993) Enhancement of recombinant tissue plasminogen activator-induced reperfusion by recombinant tick anticoagulant peptide, a selective factor Xa inhibitor, in a canine model of femoral artery thrombosis. Fibrinolysis 7:195–202

    Google Scholar 

  • Mendelsohn ME, O’Neill S, George D, Loscalzo J (1990) Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 265:19028–19034

    CAS  PubMed  Google Scholar 

  • Meng K (1975) Tierexperimentelle Untersuchungen zur antithrombotischen Wirkung von Acetylsalicylsäure. Ther Ber 47:69–79

    Google Scholar 

  • Meng K, Seuter F (1977) Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats. Naunyn Schmiedebergs Arch Pharmacol 301:115–119

    Article  CAS  PubMed  Google Scholar 

  • Meuleman DG, Hobbelen PM, Van Dinther TG, Vogel GM, Van Boeckel CA, Moelker HC (1991) Anti-factor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than the natural pentasaccharide. Semin Thromb Hemost 17(suppl 1):112–117

    PubMed  Google Scholar 

  • Millet J, Theveniaux J, Brown NL (1994) The venous antithrombotic profile of naroparcil in the rabbit. Thromb Haemost 72(6):874–879

    CAS  PubMed  Google Scholar 

  • Minsker DH, Kling PJ (1977) Bleeding time is prolonged by aspirin. Thromb Res 10:619–622

    Article  CAS  PubMed  Google Scholar 

  • Mousa SA, DeGrado WF, Mu D-X, Kapil RP, Lucchesi BR, Reilly TM (1996) Oral antiplatelet antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist. Circulation 93:537–543

    Article  CAS  PubMed  Google Scholar 

  • Mousa SA, Khurana S, Forsythe MS (2000) Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue-factor with use of thromboelastography – differentiation among glycoprotein IIb/IIIa antagonists. Arterioscler Thromb Vasc Biol 20:1162–1167

    Article  CAS  PubMed  Google Scholar 

  • Mousa SA, Abulencia JP, McCarty OJ, Turner NA, Konstantopoulos K (2002) Comparative efficacy between glycoprotein IIb/IIIa antagonists roxifiban and orbofiban in inhibiting platelet responses in flow models of thrombosis. J Cardiovasc Pharmacol 39:552–560

    Article  CAS  PubMed  Google Scholar 

  • Mousa SA, Bozarth JM, Seiffert D, Feuerstein GZ (2005) Using thrombelastography to determine the efficacy of the platelet GPIIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans. Blood Coagul Fibrinolysis 16(3):165–171

    Article  CAS  PubMed  Google Scholar 

  • Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A (1997) Altered pain reception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678–682

    Article  CAS  PubMed  Google Scholar 

  • Murray WG (1985) A preliminary study of low molecular weight heparin in aortocoronay bypass surgery. In: Murray WG (ed) Low molecular weight heparin in surgical practice (master of surgery thesis). University of London, London, pp 266

    Google Scholar 

  • Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD (2000) Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106:385–392

    Article  CAS  PubMed  Google Scholar 

  • Nicolini FA, Lee P, Rios G, Kottke-Marchant K, Topol EJ (1994) Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Circulation 89:1802–1809

    Article  CAS  PubMed  Google Scholar 

  • Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JWM, Zirngibl H, Faessler R (2001) Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 20:2120–2130

    Article  CAS  PubMed  Google Scholar 

  • Nilsson IM (1987) Assessment of blood coagulation and general hemostasis. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis, 2nd edn. Churchill Livingstone, New York, pp 922–932

    Google Scholar 

  • Nutt EM, Jain D, Lenny AB, Schaffer L, Siegl PK, Dunwiddie CT (1991) Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa. Arch Biochem Biophys 285:37–44

    Article  CAS  PubMed  Google Scholar 

  • Offermanns S, Toombs CF, Hu Y-H, Simon MI (1997) Defective platelet activation in Gαq-deficient mice. Nature 389:183–186

    Article  CAS  PubMed  Google Scholar 

  • Offermans S, Toombs CF, Hu YH, Simon MI (1997) Defective platelet activation in G alpha(q)-deficient mice. Nature 389:183–186

    Article  CAS  Google Scholar 

  • Ohlmann P, Eckly A, Freund M, Cazenave JP, Offermanns S, Gachet C (2000) ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. Blood 96:2134–2139

    CAS  PubMed  Google Scholar 

  • Ohman EM, Kleiman NS, Gacioch G, Worley SJ, Navetta FI, Talley JD, Anderson HV, Ellis SG, Cohen MD, Spriggs D, Miller M, Kereiakes D, Yakubov S, Kitt MM, Sigmon KN, Califf RM, Krucoff MW, Topol EJ (1997) Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 95:846–854

    Article  CAS  PubMed  Google Scholar 

  • Ørvim U, Brastad RM, Vlasuk GP, Sakariassen KS (1995) Effect of selective Factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis. Arterioscler Thromb Vasc Biol 15:2188–2194

    Article  PubMed  Google Scholar 

  • Oyekan AO, Botting JH (1986) A minimally invasive technique for the study of intravascular platelet aggregation in anesthetized rats. J Pharmacol Methods 15:271–277

    Article  CAS  PubMed  Google Scholar 

  • Palmer RL (1984) Laboratory diagnosis of bleeding disorders: basic screening tests. Postgrad Med 76:137–148

    CAS  PubMed  Google Scholar 

  • Panzer-Knodle S, Taite BB, Mehrotra DV, Nicholson NS, Feigen LP (1993) Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregation. J Pharmacol Toxicol Methods 30:47–53

    Article  CAS  PubMed  Google Scholar 

  • Pearson JM, Ginsburg D (1999) Use of transgenic mice in the study of thrombosis and hemostasis. In: Uprichard ACG, Gallagher KP (eds) Handbook of experimental pharmacology, vol 132. Antithrombotics. Springer, Berlin, pp 157–174

    Google Scholar 

  • Philp RB, Francey I, Warren BA (1978) Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis. Haemostasis 7:282–293

    CAS  PubMed  Google Scholar 

  • Piguet PF, Da-Laperrousaz C, Vesin C, Tacchini-Cottier F, Senaldi G, Grau GE (2000) Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect Immun 68:3822–3829

    Article  CAS  PubMed  Google Scholar 

  • Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J (1998) Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102:919–928

    Article  CAS  PubMed  Google Scholar 

  • Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D (1995) Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92:2585–2593

    Article  CAS  PubMed  Google Scholar 

  • Prism Investigators (1998) Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 338:1488–1497

    Article  Google Scholar 

  • Ramakrishnan V, Reeves PS, DeGuzman F, Deshpande U, Ministri-Madrid K (1999) Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 96:13336–13341

    Article  CAS  PubMed  Google Scholar 

  • Reimann-Hunziger G (1944) Über experimentelle Thrombose und ihre Behandlung mit Heparin. Schweiz Med Wschr 74:66–69

    Google Scholar 

  • Robbie LA, Young SP, Bennett B, Booth NA (1997) Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and PAI-1 content in distribution. Thromb Haemost 77:510–515

    CAS  PubMed  Google Scholar 

  • Rodgers RPC, Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16:1–20

    Article  CAS  PubMed  Google Scholar 

  • Roggenkamp HG, Jung F, Kiesewetter H (1983) Ein Gerät zur elektrischen Messung der Verformbarkeit von Erythrocyten. A device for the electrical measurement of the deformability of red blood cells. Biomed Tech 28:100–104

    Article  CAS  Google Scholar 

  • Romson JL, Hook BG, Lucchesi BR (1980a) Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 227:288–294

    Google Scholar 

  • Romson JL, Haack DW, Lucchesi BR (1980b) Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents. Thromb Res 17:841–853

    Article  CAS  PubMed  Google Scholar 

  • Rosen ED, Chan JCY, Idusogie E, Clotman F, Vlasuk G, Luther T, Jalbert LR, Albrecht S, Zhong L, Lissens A, Schoonjans L, Moons L, Collen D, Castellino FJ, Carmeliet P (1997) Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 390:290–294

    Article  CAS  PubMed  Google Scholar 

  • Rosenblum WI, El-Sabban F (1977) Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents. Circ Res 40:320–328

    Article  CAS  PubMed  Google Scholar 

  • Ross JM, McIntire LV, Moake JL, Rand JH (1995) Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions. Blood 85:1826–1835

    CAS  PubMed  Google Scholar 

  • Rote WE, Mu DX, Roncinske RA, Freilinger AL III, Lucchesi BR (1993) Prevention of experimental carotid artery thrombosis by Applagin. J Pharmacol Exp Ther 267:809–814

    CAS  PubMed  Google Scholar 

  • Rote WE, Davis JH, Mousa SA, Reilly TM, Lucchesi BR (1994) Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis. J Cardiovasc Pharmacol 23:681–689

    Article  CAS  PubMed  Google Scholar 

  • Rowntree LG, Shionoya T (1927) Studies in extracorporeal thrombosis. I. A method for the direct observation of extracorporal thrombus formation. II. Thrombosis formation in normal blood in the extracorporeal vascular loop. III. Effects of certain anticoagulants (heparin and hirudin) on extracorporeal thrombosis and on the mechanism of thrombus formation. J Exp Med 46:7–26

    Article  CAS  PubMed  Google Scholar 

  • Rübsamen K, Hornberger W (1996) Prevention of early reocclusion after thrombolysis of copper-coil-induced thrombi in the canine coronary artery: comparison of PEG-hirudin and unfractionated heparin. Thromb Haemost 76:105–110

    PubMed  Google Scholar 

  • Ruebsamen K, Kirchengast M (1998) Thrombin inhibition and intracoronary thrombus formation: effect of polyethylene glycol-coupled hirudin in the stenosed, locally injured canine coronary artery. Coron Artery Dis 9:35–42

    Article  Google Scholar 

  • Sakariassen KS, Aarts PA, De Groot PG, Houdijk WP, Sixma JJ (1983) A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 102:522–535

    CAS  PubMed  Google Scholar 

  • Sakariassen KS, Muggli R, Baumgartner HR (1989) Measurements of platelet interaction with components of the vessel wall in flowing blood. Methods Enzymol 169:37–70

    Article  CAS  PubMed  Google Scholar 

  • Sakariassen KS, Joss R, Muggli R, Kuhn H, Tschopp TB, Sage H, Baumgartner HR (1990) Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis 10:276–284

    Article  CAS  PubMed  Google Scholar 

  • Salazar AE (1961) Experimental myocardial infarction, induction of coronary thrombosis in the intact closed-chest dog. Circ Res 9:135–136

    Google Scholar 

  • Sanderson PEJ, Cutrona KJ, Dorsey BD, Dyer DL, McDonough CM, Naylor-Olsen AM, Chen I-W, Chen Z, Cook JJ, Gardell SJ, Krueger JA, Lewis SD, Lin JH, Lucas BJ, Lyle EA, Lynch JJ, Stranieri MT, Vastag K, Shafer JA, Vacca JP (1998) L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor. Bioorg Med Chem Lett 8:817–822

    Article  CAS  PubMed  Google Scholar 

  • Sato K, Kawasaki T, Hisamichi N, Taniuchi Y, Hirayama F, Koshio H, Matsumoto Y (1998) Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time. Br J Pharmacol 123:92–96

    Article  CAS  PubMed  Google Scholar 

  • Sawyer PN, Pate JW (1953) Bioelectric phenomena as an etiologic factor in intravascular thrombosis. Am J Physiol 175:103–107

    CAS  PubMed  Google Scholar 

  • Sawyer PN, Pate JW, Weldon CS (1953) Relations of abnormal and injury electric potential differences to intravascular thrombosis. Am J Physiol 9:108–112

    Google Scholar 

  • Scherer RU, Giebler RM, Schmidt U, Paar D, Wust T, Spangenberg P, Militzer K, Hirche H, Kox WJ (1995) Short-time rabbit model of endotoxin-induced of hypercoagulability. Lab Anim Sci 45:538–546

    CAS  PubMed  Google Scholar 

  • Schmid-Schoenbein H, Gosen J, Heinich L, Klose HJ, Volger E (1973) A counter-rotating “Rheoscope chamber” for the study of the microrheology of blood cell aggregation by microscopic observation and microphotometry. Microvasc Res 6:366–376

    Article  Google Scholar 

  • Schumacher WA, Steinbacher TE, Megill JR, Durham SK (1996a) A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin. J Pharmacol Toxicol Methods 35:3–10

    Article  CAS  PubMed  Google Scholar 

  • Schumacher WA, Heran CL, Steinbacher TE (1996b) Low-molecular-weight heparin (Fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time. J Cardiovasc Pharmacol 28:19–25

    Article  CAS  PubMed  Google Scholar 

  • Scott NA, Nunes GL, King SB III, Harker LA, Hanson SR (1994) Local delivery of an antithrombin inhibits platelet-dependent thrombosis. Circulation 90:1951–1955

    Article  CAS  PubMed  Google Scholar 

  • Seiffge D, Behr S (1986) Passage time of red blood cells in the SER; their distribution and influences of various extrinsic and intrinsic factors. Clin Hemorheol 6:151–164

    Google Scholar 

  • Seiffge D, Kremer E (1984) Antithrombotic effects of pentoxifylline on laser-induced thrombi in rat mesenteric arteries. IRCS Med Sci 12:91–92

    CAS  Google Scholar 

  • Seiffge D, Kremer E (1986) Influence of ADP, blood flow velocity, and vessel diameter on the laser-induced thrombus. Thromb Res 42:331–341

    Article  CAS  PubMed  Google Scholar 

  • Seiffge D, Weithmann U (1987) Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation. Thromb Res 46:371–383

    Article  CAS  PubMed  Google Scholar 

  • Seuter F, Busse WD, Meng K, Hoffmeister F, Möller E, Horstmann H (1979) The antithrombotic activity of BAY g 6575. Arzneim Forsch/Drug Res 29:54–59

    CAS  Google Scholar 

  • Shebuski RJ, Storer BL, Fujita T (1988) Effect of thromboxane synthetase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis. Thromb Res 52:381–392

    Article  CAS  PubMed  Google Scholar 

  • Sixma JJ, De Groot PG, Van Zanten H, IJsseldijk M (1998) A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res 92:S43–S46

    Article  CAS  PubMed  Google Scholar 

  • Sloan MA, Gore JM (1992) Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis. Am J Cardiol 69:21A–38A

    Article  CAS  PubMed  Google Scholar 

  • Smith D, Sanjar S, Herd C, Morley J (1989) In vivo method for the assessment of platelet accumulation. J Pharmacol Methods 21:45–59

    Article  CAS  PubMed  Google Scholar 

  • Spokas EG, Wun TC (1992) Venous thrombosis produced in the vena cava of rabbits by vascular damage and stasis. J Pharmacol Toxicol Methods 27:225–232

    Article  CAS  PubMed  Google Scholar 

  • Stella L, Donati MB, Gaetano G (1975) Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thromb Res 7:709–716

    Article  CAS  PubMed  Google Scholar 

  • Stieg PE, Kase CS (1998) Intracranial hemorrhage: diagnosis and emergency management. Neurol Clin 16:373–390

    Article  CAS  PubMed  Google Scholar 

  • Stockmans F, Stassen JM, Vermylen J, Hoylaerts MF, Nystrom A (1997) A technique to investigate mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r-hirudin and G-4120. Ann Plast Surg 38(1):63–68

    Article  CAS  PubMed  Google Scholar 

  • Stone P, Lord JW (1951) An experimental study of the thrombogenic properties of magnesium-aluminum wire in the dog’s aorta. Surgery 30:987–993

    CAS  PubMed  Google Scholar 

  • Stringer HAR, Van Swieten P, Heijnen HFG, Sixma JJ, Pannekoek H (1994) Plasminogen activator inhibitor 1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop. Arterioscler Thromb 14:1452–1458

    Article  CAS  PubMed  Google Scholar 

  • Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD (1996) Defects in hemostasis in P-selectin-deficient mice. Blood 87:1238–1242

    CAS  PubMed  Google Scholar 

  • Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter SS, Degen JL (1995) Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9:2020–2033

    Article  CAS  PubMed  Google Scholar 

  • Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmbäck K, Xiao Q, Bugge TH, Degen SJF (1998) Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 95:7597–7602

    Article  CAS  PubMed  Google Scholar 

  • Sweeney JD, Labuzzetta JW, Michielson CE, Fitzpatrick JE (1989) Whole blood aggregation using impedance and particle counter methods. Am J Clin Pathol 92:794–797

    CAS  PubMed  Google Scholar 

  • Tada M, Esumi K, Yamageshi M, Kuzuya T, Matsuda H, Abe H, Uchida Y, Murao S (1984) Reduction of prostaglandin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery. Mol Cell Biol 16:1137–1149

    CAS  Google Scholar 

  • Taniuchi Y, Sakai Y, Hisamichi N, Kayama M, Mano Y, Sato K, Hirayama F, Koshio H, Matsumoto Y, Kawasaki T (1998) Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human Factor Xa. Thromb Haemost 79:543–548

    CAS  PubMed  Google Scholar 

  • Teitel P (1977) Basic principles of the “Filterability test” (FT) and analysis of erythrocyte flow behavior. Blood Cells 3:55–70

    Google Scholar 

  • Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM (1998) Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102:1994–2001

    Article  CAS  PubMed  Google Scholar 

  • Tidwell RR, Webster WP, Shaver SR, Geratz JD (1980) Strategies for anticoagulation wit synthetic protease inhibitors.Xa inhibitors versus thrombin inhibitors. Thromb Res 19:339–349

    Article  CAS  PubMed  Google Scholar 

  • Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y (1996) Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost 75:838–843

    CAS  PubMed  Google Scholar 

  • Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88:1583–1587

    CAS  PubMed  Google Scholar 

  • Toomey JR, Kratzer KE, Lasky NM, Broze GJ (1997) Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA 94:6922–6926

    Article  CAS  PubMed  Google Scholar 

  • Tronik-Le Roux D, Roullot V, Poujol C, Kortulewski T, Nurden P, Marguerie G (2000) Thrombasthenic mice generated by replacement of the integrin alphaIIb gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment. Blood 96:1399–1408

    CAS  PubMed  Google Scholar 

  • Turitto VT (1982) Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb 6:139–177

    CAS  PubMed  Google Scholar 

  • Uchida Y, Yoshimoto N, Murao S (1975) Cyclic fluctuations in coronary blood pressure and flow induced by coronary artery constriction. Jpn Heart J 16:454–464

    Article  CAS  PubMed  Google Scholar 

  • Van Giezen JJ, Wahlund G, Nerme J, Abrahamsson T (1997) The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis. Thromb Haemost 77:964–969

    PubMed  Google Scholar 

  • Van Giezen JJJ, Nerme V, Abrahamsson T (1998) PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood. Blood Coagul Fibrinolysis 9:11–18

    Article  PubMed  Google Scholar 

  • Van Wyk V, Neethling WML, Badenhorst PN, Kotze HF (1998) r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons. J Cardiovasc Surg 39:633–639

    Google Scholar 

  • Vassalli G, Dichek DA (1997) Gene therapy for arterial thrombosis. Cardiovasc Res 35:459–469

    Article  CAS  PubMed  Google Scholar 

  • Virchow R (1856) Über die Verstopfung der Lungenarterie. In: Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Meidinger Sohn, Frankfurt, p 221

    Google Scholar 

  • Vlasuk GP, Ramjit D, Fujita T, Dunwiddie CT, Nutt EM, Smith DE, Shebuski RJ (1991) Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors anti-stasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis. Thromb Haemost 65(3):257–262

    CAS  PubMed  Google Scholar 

  • Völkl K-P, Dierichs R (1986) Effect of intravenously injected collagenase on the concentration of circulating platelets in rats. Thromb Res 42:11–20

    Article  PubMed  Google Scholar 

  • Walenga JM, Fareed J, Petitou M, Samama M, Lormeau JC, Choay J (1986) Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model. Thromb Res 43(2):243–248

    Article  CAS  PubMed  Google Scholar 

  • Walenga JM, Petitou M, Lormeau JC, Samama M, Fareed J, Choay J (1987) Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges. Thromb Res 46(2):187–198

    Article  CAS  PubMed  Google Scholar 

  • Wang L, Zoppè M, Hackeng TM, Griffin JH, Lee K-F, Verma IM (1997) A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci USA 94:11563–11566

    Article  CAS  PubMed  Google Scholar 

  • Wang D, Feng J, Wen R, Marine JC, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ, Ihle JN (2000) Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 13:25–35

    Article  PubMed  Google Scholar 

  • Ware J, Russell S, Ruggeri ZM (2000) Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA 97:2803–2808

    Article  CAS  PubMed  Google Scholar 

  • Warltier DC, Lamping KA, Pelc LR, Gross GJ (1987) A canine model of thrombin-induced coronary artery thrombosis: effects of intracoronary streptokinase on regional myocardial blood flow, contractile function, and infarct size. J Pharmacol Methods 18:305–318

    Article  CAS  PubMed  Google Scholar 

  • Waugh JM, Yuksel E, Li J, Kuo MD, Kattash M, Saxena R, Geske R, Thung SN, Shenaq SM, Woo SL (1999a) Local over-expression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ Res 84:84–92

    Article  CAS  PubMed  Google Scholar 

  • Waugh JM, Kattash M, Li J, Yuksel E, Kuo MD, Lussier M, Weinfeld AB, Saxena R, Rabinovsky ED, Thung S, Woo SL, Shenaq SM (1999b) Gene therapy to promote thromboresistance: local over-expression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model. Proc Natl Acad Sci USA 96:1065–1070

    Article  CAS  PubMed  Google Scholar 

  • Weichert W, Pauliks V, Breddin HK (1983) Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs. Haemostasis 13:61–71

    CAS  PubMed  Google Scholar 

  • Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW (1998) A targeted point mutation in thrombomodulin generates viable mice with a prothrombotic state. J Clin Invest 101:1983–1991

    Article  CAS  PubMed  Google Scholar 

  • Wessler S (1952) Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments. J Clin Invest 31:1011–1014

    Article  CAS  PubMed  Google Scholar 

  • Wessler S (1953) Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments. J Clin Invest 32:650–654

    Article  CAS  PubMed  Google Scholar 

  • Wessler S (1955a) Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J Clin Invest 34:647–651

    Article  CAS  PubMed  Google Scholar 

  • Wessler S (1955b) Studies in intravascular coagulation. IV. The effect of dicumarol and heparin on serum-induced venous thrombosis. Circulation 12:553–556

    Article  CAS  PubMed  Google Scholar 

  • Wessler S (1957) Studies in intravascular coagulation. V. A distinction between the anticoagulant and antithrombotic effects of dicumarol. N Engl J Med 256:1223–1225

    Article  CAS  PubMed  Google Scholar 

  • Wessler S, Reimer SM, Sheps MC (1959) Biologic assay of a thrombosis-inducing activity in human serum. J Appl Physiol 14:943–946

    CAS  PubMed  Google Scholar 

  • Wysokinski W, McBane R, Chesebro JH, Owen WG (1996) Reversibility of platelet thrombosis in vivo. Thromb Haemost 76:1108–1113

    CAS  PubMed  Google Scholar 

  • Xiao Z, Théroux P (1998) Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 97:251–256

    Article  CAS  PubMed  Google Scholar 

  • Xu J, Wu Q, Westfield L, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95:7603–7607

    Article  Google Scholar 

  • Xue J, Wu Q, Westfield L, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95:7603–7607

    Article  CAS  PubMed  Google Scholar 

  • Yamazaki M, Asakura H, Aoshima K, Saito M, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Ikeda T, Matsuda T (1994) Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats. Thromb Haemost 72:393–396

    CAS  Google Scholar 

  • Yang TL, Cui J, Taylor JM, Yang A, Ginsburg GSB (2000a) Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression. Thromb Haemost 83:70–77

    CAS  PubMed  Google Scholar 

  • Yang J, Wu J, Kowalska MA, Dalvi A, Prevost N, O’Brien PJ, Manning D, Poncz M, Lucki I, Blendy JA, Brass LF (2000b) Loss of signaling through G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 97:9984–9989

    Article  CAS  PubMed  Google Scholar 

  • Yasuda T, Gold HK, Fallon JT, Leinbach RC, Guerrero JL, Scudder LE, Kanke M, Shealy D, Ross MJ, Collen D, Coller B5 (1988) Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue type plasminogen activator. J Clin Invest 81:1284–1291

    Article  CAS  PubMed  Google Scholar 

  • Yokoyama T, Kelly AB, Marzec UM, Hanson SR, Kunitada S, Harker LA (1995) Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Circulation 92:485–491

    Article  CAS  PubMed  Google Scholar 

  • Yoshida K, Gould KL (1993) Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 22:984–997

    Article  CAS  PubMed  Google Scholar 

  • Zawilska KM, Born GVR, Begent NA (1982) Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits. Br J Haematol 50:317–325

    Article  CAS  PubMed  Google Scholar 

  • Zheng X, Sunders TL, Camper SA, Samuelson LC, Ginsburg D (1995) Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 92:12426–12430

    Article  CAS  PubMed  Google Scholar 

  • Zoldhelyi P, McNatt J, Shelat HS, Yamamoto Y, Chen ZQ, Willerson JT (2000) Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor. Circulation 101:289–295

    Article  CAS  PubMed  Google Scholar 

  • Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA (1981) Comparison of thrombelastography with common coagulation tests. Thromb Haemost 46:752–756

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, 12144, Albany, NY, USA

    Dr. Shaker A. Mousa

Authors
  1. Dr. Shaker A. Mousa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shaker A. Mousa .

Editor information

Editors and Affiliations

  1. Sanofi Pharma Deutschland GmbH, A company of the Sanofi-Aventis Group Industriepark Hoechst, Frankfurt am Main, Germany

    Jochen Maas

  2. Dieburg, Germany

    Franz J. Hock

  3. Idstein, Germany

    Dieter Mayer

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Mousa, S.A. (2013). Blood Constituents and Safety Pharmacology. In: Vogel, H.G., Maas, J., Hock, F.J., Mayer, D. (eds) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25240-2_12

Download citation

Publish with us

Policies and ethics

Search

Navigation